BioReact
PrivateLast Round
Seed
Feb 12, 2026
Total Funding Raised
$1.31M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioReact is a biotechnology software company that provides an AI-powered platform for bioprocess optimization, enabling scientists to automate data alignment, visualize experiments, and predict optimal growth conditions for biopharma, synthetic biology, and industrial biotech applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Vertical SaaS, Drug Discovery
Business Model
B2B
Customer Profile
Subscription SaaS, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioReact Comparables
Compare BioReact with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioRaptor | 88% | |
| Invert | 85% | |
| Novasign GmbH | 80% |
BioReact Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 12, 2026 | ||||
| Pre Seed | Jan 21, 2026 | ||||
| Accelerator | Nov 3, 2024 | ||||
| Seed | Sep 3, 2024 | ||||
| Accelerator | Apr 17, 2024 |
Key People
Founding team and executive leadership
BioReact Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Accelerator, Pre Seed, Seed |
| Newstack Ventures | Pre Seed |
| FortySix Capital | Seed |
| gBETA | Accelerator |
| JPMorgan Chase & Co. | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 42% month-over-month.
- Feb 12, 2026
Seed round raised from FortySix Capital, hurricaneventures, and The University of Tulsa.
BioReact Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioReact's valuation, stock price, and market status.
Is BioReact a public or private company?
BioReact is a private company.
What is the current stock price of BioReact?
BioReact is a private company with no public stock price. No recent secondary market data is available.
How much is BioReact worth (valuation)?
Valuation information for BioReact is not publicly available.
Can I buy BioReact stock?
BioReact shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BioReact's last funding round?
BioReact's most recent funding round was Seed on September 3, 2024.
Who are the main investors in BioReact?
Key investors in BioReact include Techstars, gBETA.
Will BioReact IPO soon?
No public IPO plans have been announced for BioReact.
How can I track BioReact secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioReact's secondary market activity and sign up for updates.